Your browser doesn't support javascript.
loading
Statin treatment rescues FGFR3 skeletal dysplasia phenotypes.
Yamashita, Akihiro; Morioka, Miho; Kishi, Hiromi; Kimura, Takeshi; Yahara, Yasuhito; Okada, Minoru; Fujita, Kaori; Sawai, Hideaki; Ikegawa, Shiro; Tsumaki, Noriyuki.
Afiliación
  • Yamashita A; Cell Induction and Regulation Field, Department of Cell Growth and Differentiation, Center for iPS Cell Research and Application, Kyoto University, Kyoto 606-8507, Japan.
  • Morioka M; Cell Induction and Regulation Field, Department of Cell Growth and Differentiation, Center for iPS Cell Research and Application, Kyoto University, Kyoto 606-8507, Japan.
  • Kishi H; Cell Induction and Regulation Field, Department of Cell Growth and Differentiation, Center for iPS Cell Research and Application, Kyoto University, Kyoto 606-8507, Japan.
  • Kimura T; 1] Cell Induction and Regulation Field, Department of Cell Growth and Differentiation, Center for iPS Cell Research and Application, Kyoto University, Kyoto 606-8507, Japan [2] Department of Pediatrics, Osaka University Graduate School of Medicine, Osaka 565-0871, Japan.
  • Yahara Y; Cell Induction and Regulation Field, Department of Cell Growth and Differentiation, Center for iPS Cell Research and Application, Kyoto University, Kyoto 606-8507, Japan.
  • Okada M; Cell Induction and Regulation Field, Department of Cell Growth and Differentiation, Center for iPS Cell Research and Application, Kyoto University, Kyoto 606-8507, Japan.
  • Fujita K; Cell Induction and Regulation Field, Department of Cell Growth and Differentiation, Center for iPS Cell Research and Application, Kyoto University, Kyoto 606-8507, Japan.
  • Sawai H; Department of Obstetrics and Gynecology, Hyogo College of Medicine, Hyogo 663-8501, Japan.
  • Ikegawa S; Laboratory of Bone and Joint Diseases, Center for Integrated Medical Sciences, RIKEN, Tokyo 108-8639, Japan.
  • Tsumaki N; 1] Cell Induction and Regulation Field, Department of Cell Growth and Differentiation, Center for iPS Cell Research and Application, Kyoto University, Kyoto 606-8507, Japan [2] Japan Science and Technology Agency, CREST, Tokyo 102-0075, Japan.
Nature ; 513(7519): 507-11, 2014 Sep 25.
Article en En | MEDLINE | ID: mdl-25231866
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Acondroplasia / Displasia Tanatofórica / Inhibidores de Hidroximetilglutaril-CoA Reductasas / Receptor Tipo 3 de Factor de Crecimiento de Fibroblastos Tipo de estudio: Prognostic_studies Idioma: En Revista: Nature Año: 2014 Tipo del documento: Article País de afiliación: Japón Pais de publicación: Reino Unido
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Acondroplasia / Displasia Tanatofórica / Inhibidores de Hidroximetilglutaril-CoA Reductasas / Receptor Tipo 3 de Factor de Crecimiento de Fibroblastos Tipo de estudio: Prognostic_studies Idioma: En Revista: Nature Año: 2014 Tipo del documento: Article País de afiliación: Japón Pais de publicación: Reino Unido